We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience. You can read our Cookie Policy here.

Advertisement
BlueGnome Launches Application Specific SNP Microarray Platforms
Product News

BlueGnome Launches Application Specific SNP Microarray Platforms

BlueGnome Launches Application Specific SNP Microarray Platforms
Product News

BlueGnome Launches Application Specific SNP Microarray Platforms


Want a FREE PDF version of This Product News?

Complete the form below and we will email you a PDF version of "BlueGnome Launches Application Specific SNP Microarray Platforms"

First Name*
Last Name*
Email Address*
Country*
Company Type*
Job Function*
Would you like to receive further email communication from Technology Networks?

Technology Networks Ltd. needs the contact information you provide to us to contact you about our products and services. You may unsubscribe from these communications at any time. For information on how to unsubscribe, as well as our privacy practices and commitment to protecting your privacy, check out our Privacy Policy

BlueGnome, now offers two SNP microarray formats to simultaneously detect copy number imbalance at high resolution and LOH/UPD (loss of heterozygosity/uniparental isodysomy) in the same assay.

It is not possible to detect copy number neutral LOH/UPD using standard array CGH (comparative genomic hybridization).

Well known conditions, such as, Prader-Willi syndrome, Angelman syndrome, Zellweger syndrome and Beckwith-Wiedemann syndrome can therefore be missed without a SNP specific assay. Copy neutral LOH or acquired UPD is also important in cancer.

BlueGnome now supplies the CytoChip SNP 4x180K microarray for investigation of constitutional samples, based on the international standard ISCA design, plus SNP specific probes that enable 10 Mb LOH detection.

For cancer sample investigation, the CytoChip Cancer SNP 4x180K includes a gene enriched design for copy number imbalance, plus SNP probes that detect on average 5 Mb LOH. BlueGnome intends to extend the range of SNP array designs available in the future.

Nick Haan, BlueGnome’s CEO, said, “The new SNP platforms can be fully incorporated into the CytoChip workflow with very little modification to laboratory practice or to analysis, allowing customers to incorporate the new assays with ease. Microarrays that detect LOH are a welcome addition to our product range.”

Advertisement